BR0110926A - Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos - Google Patents

Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos

Info

Publication number
BR0110926A
BR0110926A BR0110926-0A BR0110926A BR0110926A BR 0110926 A BR0110926 A BR 0110926A BR 0110926 A BR0110926 A BR 0110926A BR 0110926 A BR0110926 A BR 0110926A
Authority
BR
Brazil
Prior art keywords
preparation process
amorphous forms
new amorphous
omeprazole salts
omeprazole
Prior art date
Application number
BR0110926-0A
Other languages
English (en)
Inventor
Bakthavathsalan Vijayaraghavan
Naresh Kumar
Tarun Sharma
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0110926A publication Critical patent/BR0110926A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"NOVAS FORMAS AMORFAS DE SAIS DE OMEPRAZOL E PROCESSO DE PREPARAçãO DOS MESMOS". A presente invenção refere-se a novas formas amorfas de sais e processos de preparação destes.
BR0110926-0A 2000-05-15 2001-05-11 Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos BR0110926A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN516DE2000 2000-05-15
PCT/IB2001/000820 WO2001087831A2 (en) 2000-05-15 2001-05-11 Novel amorphous form of omeprazole salts

Publications (1)

Publication Number Publication Date
BR0110926A true BR0110926A (pt) 2004-02-17

Family

ID=11097053

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110926-0A BR0110926A (pt) 2000-05-15 2001-05-11 Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos

Country Status (7)

Country Link
US (1) US20030212274A1 (pt)
EP (1) EP1706397A4 (pt)
CN (1) CN1437593A (pt)
AU (1) AU5248601A (pt)
BR (1) BR0110926A (pt)
CA (1) CA2409258A1 (pt)
WO (1) WO2001087831A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
US7612098B2 (en) 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
ATE508124T1 (de) 2003-03-24 2011-05-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von amorphem rabeprazole-natrium-salz
ES2246149B1 (es) 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
CA2591983A1 (en) * 2004-12-20 2006-06-29 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions comprising amorphous benzimidazole compounds
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
WO2006087613A2 (en) * 2005-02-02 2006-08-24 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions prepared by non-aqueous layering process
WO2006096709A2 (en) * 2005-03-08 2006-09-14 Dr. Reddy's Laboratories Ltd. Process for preparing amorphous salts
EP1726305A1 (de) * 2005-05-25 2006-11-29 Ratiopharm GmbH Zinksalz des Omeprazols und dessen Enantiomere
WO2006131338A2 (en) 2005-06-08 2006-12-14 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
JP2010519284A (ja) 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
US6262085B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole

Also Published As

Publication number Publication date
US20030212274A1 (en) 2003-11-13
WO2001087831A3 (en) 2002-03-28
WO2001087831A2 (en) 2001-11-22
CA2409258A1 (en) 2001-11-22
EP1706397A4 (en) 2007-08-01
EP1706397A2 (en) 2006-10-04
CN1437593A (zh) 2003-08-20
AU5248601A (en) 2001-11-26

Similar Documents

Publication Publication Date Title
BR0110926A (pt) Novas formas amorfas de sais de omeprazol e processo de preparação dos mesmos
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
BR0307529A (pt) Derivados de n-fenil-2-pirimidina-amina
DE60220475D1 (de) Verfahren zur Herstellung quaternärer Ammoniumsalze von Hydroxycarbonsäuren und quaternärer Ammoniumsalze anorganischer Säuren
FR2831805B1 (fr) Procede de deformation permanente des cheveux mettant en oeuvres des silicones aminees particulieres
DE69604172T2 (de) Vorrichtung mit internen asymmetrischen merkmalen zur rotatorischen ausrichtung von nicht-symmetrischen artikeln
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
BR0112665A (pt) Sais
DE60102016D1 (de) Verfahren zur behandlung von beweggungsstörungen
DE60137836D1 (de) Vorrichtung zur Bearbeitung von Brillengläsern
NO20024623D0 (no) Ny fremgangsmåte for fremstilling av kondensert imidazopyridinderivat og ny krystallform
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
BR0211691A (pt) Processo para a prepara de tolterodina
BR0110357A (pt) Sais bicìclicos e n-aciclados de aminas imidazo - 3 e imidazo -5
BR9609182A (pt) Processo de hidrólise contínua para preparação de ácido-2-hidroxi-4-metiltiobutanóico ous sais do mesmo
PT1472221E (pt) Indois substituidos, processo para a sua producao e utilizacao na inibicao de dor
PT1198466E (pt) Processo para producao de glifosatos ou um dos seus sais
DE60107074D1 (de) Kristallin form ii von cabergolin
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE50115204D1 (de) Anlage zum formbearbeiten der ränder von brillengläsern
BR0002693B1 (pt) Processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
BR9915549A (pt) Copolìmeros acoplados em bloco e processo paraa produção dos copolìmeros em bloco
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
PT1326836E (pt) Processo de producao de 3-amido-2-cloro-4-metilpiridina
BR0108489B1 (pt) processo para a produção de n-(fosfonometil) glicina.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired